Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evotec SE (EVO) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for Evotec SE (EVO) over the last 9 years, with Q3 2025 value amounting to $209578.8.

  • Evotec SE's Cash & Equivalents fell 1749.38% to $209578.8 in Q3 2025 from the same period last year, while for Sep 2025 it was $209578.8, marking a year-over-year decrease of 1749.38%. This contributed to the annual value of $327403.7 for FY2024, which is 9994.96% down from last year.
  • As of Q3 2025, Evotec SE's Cash & Equivalents stood at $209578.8, which was down 1749.38% from $346817.7 recorded in Q2 2025.
  • In the past 5 years, Evotec SE's Cash & Equivalents ranged from a high of $800.0 million in Q4 2021 and a low of $209578.8 during Q3 2025
  • Over the past 5 years, Evotec SE's median Cash & Equivalents value was $508901.0 (recorded in 2021), while the average stood at $99.0 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 5878.3% in 2021, then tumbled by 9994.96% in 2024.
  • Evotec SE's Cash & Equivalents (Quarter) stood at $800.0 million in 2021, then plummeted by 47.06% to $423.6 million in 2022, then surged by 53.46% to $650.0 million in 2023, then crashed by 99.95% to $327403.7 in 2024, then crashed by 35.99% to $209578.8 in 2025.
  • Its Cash & Equivalents stands at $209578.8 for Q3 2025, versus $346817.7 for Q2 2025 and $300183.6 for Q1 2025.